• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • OLINK Services
    • Biomarker Data Analyses
  • R&D
  • Products
    • NEUROLINCS
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media
Reasons for hope on World Alzheimer’s Day

Reasons for hope on World Alzheimer’s Day

 

21st September : World Alzheimer's Day. 📅

 

Our company actively contributes to the fight against Alzheimer's disease by developing a program with the aim of validating the clinical performance of the best non-coding RNA panel, which would allow the early diagnosis of Alzheimer's disease (AD)

 

As you know, Bill Gates, a longtime supporter of Alzheimer's research and initial partner of the ADDF's Diagnostics Accelerator (DxA), a global research initiative dedicated to fast-tracking the development of affordable and accessible diagnostic tools and biomarkers.

 

Firalis and its affiliate AMONETA Diagnostics develops new diagnostic and therapeutic tools based on non-coding RNAs thanks to the ADDF funding within the DxA initiative.

 

In his latest Gates Notes, Gates, who recently lost his father to Alzheimer’s disease, captures the reality for families of patients with Alzheimer’s and his optimism that this will soon be very different.

 

https://www.gatesnotes.com/Health/New-breakthroughs-in-Alzheimers-diagnostics?WT.mc_id=20210920160000_Alzheimers-diagnostics_BG-EM_&WT.tsrc=BGEM

21.09.2021

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE